DEVELOPMENT OF SUPEROXIDE DISMUTASE MIMICS

超氧化物歧化酶模拟物的开发

基本信息

  • 批准号:
    3774576
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Our laboratory has shown that nitroxides, which have been used as EPR spin labels exhibit superoxide dismutase (SOD) activity and are quite effective agents in protecting cells against a wide variety of oxidative stresses. Our lead compound, Tempol, a water soluble nitroxide has been shown to protect mammalian cells against superoxide generated from xanthine/xanthine oxidase, and direct hydrogen peroxide cytotoxicity. We have demonstrated that Tempol protects both cells in vitro and mice against ionizing radiation. Thus, the nitroxides represent a new class of radiation protectors that may have widespread use in protecting humans against radiation. Preliminary studies using a rodent tumor model have shown that Tempol does not protect tumor tissue. Further chemical characterization of the SOD mimic activity of nitroxides has revealed the presence of an oxoammonium cation intermediate. This information will be used to identify for maximal protective capacity based on their oxidation potential and charge. Tempol has been shown to protect cells against mutation induction mediated by superoxide, hydrogen peroxide, and radiation. Tempol has also been shown to protect cells exposed to various chemotherapy drugs including mitomycin C and SR-4233. Not only might these agents be useful in protecting against certain chemotherapy agents but should be instructive in determining mechanisms of action. Topically applied, Tempol has been shown to protect against radiation- induced alopecia in guinea pigs. It has also been shown to be a novel class of anti-ulcerogenic compounds. Since these agents readily penetrate cell membranes, they may be of use in other areas of medical research such as ischemia/reperfusion injury studies. Furthermore, these studies have opened the possibility of inter-relating the biochemistry and metabolism of nitroxides to endogenously produced endothelial relaxation factor, nitric oxide.
我们的实验室已经证明,氮氧化物已经被用作EPR

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A RUSSO其他文献

A RUSSO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A RUSSO', 18)}}的其他基金

INTRACELLULAR MODULATION OF SPECIFIC INTRACELLULAR PROTEINS
特定细胞内蛋白质的细胞内调节
  • 批准号:
    2464488
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
RELATIONSHIP OF CELLULAR REDOX STATE AND THERMOTOLERANCE
细胞氧化还原态与耐热性的关系
  • 批准号:
    3939515
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
INTRACELLULAR MODULATION OF SPECIFIC INTRACELLULAR PROTEINS
特定细胞内蛋白质的细胞内调节
  • 批准号:
    3752415
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
氮氧化物作为氧化应激的保护剂
  • 批准号:
    3752336
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PHOTOTHERAPY OF INTRACAVITARY SPACES
腔内空间的光疗
  • 批准号:
    3916586
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISMS OF RADIOPROTECTION
辐射防护机制
  • 批准号:
    4692120
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
RELATIONSHIP OF CELLULAR REDOX STATE AND THERMOTOLERANCE
细胞氧化还原态与耐热性的关系
  • 批准号:
    3963241
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR BIOLOGY--TISSUE CULTURE CORE FACILITY
分子生物学--组织培养核心设施
  • 批准号:
    3854423
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR BIOLOGY--TISSUE CULTURE CORE FACILITY
分子生物学--组织培养核心设施
  • 批准号:
    3896917
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REDIRECTION OF REDOX PROTEINS TO THE NUCLEUS OF EUKARYOTIC CELLS
氧化还原蛋白重定向至真核细胞的细胞核
  • 批准号:
    3752414
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia
低强度超声的临床前测试作为预防化疗引起的脱发人源化小鼠模型中紫杉醇引起的毛囊损伤的新策略
  • 批准号:
    10722518
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Influence of the Microbiome on the Natural History of Alopecia Areata
微生物组对斑秃自然史的影响
  • 批准号:
    10585677
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Scalp cooling for the prevention of chemotherapy-induced alopecia: increasing patient access through eco-design and innovative manufacturing.
头皮冷却预防化疗引起的脱发:通过生态设计和创新制造增加患者接触机会。
  • 批准号:
    10014407
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
The role of the hair follicle and its environment in androgenetic alopecia
毛囊及其环境在雄激素性脱发中的作用
  • 批准号:
    2735136
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship
Aire-dependent regulation of spontaneous autoimmune-mediated alopecia
自发性自身免疫介导的脱发的空气依赖性调节
  • 批准号:
    10464297
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Epithelial-immune microenvironment (EIME) in alopecia areata
斑秃的上皮免疫微环境(EIME)
  • 批准号:
    21K08348
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
IL-27 and downstream mechanisms in Alopecia Areata
斑秃中的 IL-27 及其下游机制
  • 批准号:
    10685308
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Investigating the role of IKZF1 in alopecia areata
研究 IKZF1 在斑秃中的作用
  • 批准号:
    21K16234
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
IL-27 and downstream mechanisms in Alopecia Areata
IL-27 及其下游机制在斑秃中的作用
  • 批准号:
    10490304
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia
便携式、患者管理的头皮冷却帽可减轻提供者的负担,改善患者的接触,并改善化疗引起的脱发患者的治疗效果
  • 批准号:
    10480105
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了